samedan logo
 
 
 
spacer
home > pmps > summer 2019 > all about the box
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

All About the Box

In December 2016, a pharmacist in Northern Ireland made a tragic error when he fatally dispensed propranolol to a patient who was prescribed prednisolone. It was revealed that the two boxes were side-by-side on the pharmacy’s shelf, with similar branding and packaging. Such simple slip-ups can result in devastation and highlight packaging’s crucial role in keeping patients safe.

Even to the trained eye of a busy pharmacist, medication names such as Daptomycin and Dactinomycin or Levoxine and Lanoxin could be easily muddled, especially if they share similar dosages and are packaged in indistinguishable white cardboard boxes.

Incorrect dispensing is just one issue that can arise from ineffective packaging. Dangerous storage conditions, medication tampering, and the production of counterfeit medicine can all occur when packaging is not as effective as it should be. What can we do to prevent these problems before they jeopardise public health?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Oliver Pittock is the Managing Director at pharma packaging specialist Valley Northern. Oliver built his commitment to the healthcare and pharmacy supply business through seeing his father’s business grow throughout the 1970s. Moving to the Midlands in 1993, Oliver set up Valley Northern, which became a limited company in 2014.
spacer
Oliver Pittock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ADM Supports Clinical Trial into Effects of Probiotic Supplements for COVID-19 Patients in Hospital Care

ADM and Hospital de Sagunto, one of the largest medical centers in the Valencia region, today announce their partnership for a clinical trial into the effects of using a food supplement containing live microbial strains to promote gut microbiome balance and help improve health functions related to outcomes for COVID-19 patients in high-risk groups. On 18th March Dr Xavier Cortés, gastroenterologist at Hospital de Sagunto, communicated with medical staff in China who had observed that many COVID-19 patients had exhibited abnormal changes in their gut microbiome.
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement